FDA places clinical hold on Regeneron and Teva’s pain drug trial
The drug is being developed and commercialized jointly by Regeneron Pharmaceuticals and Teva Pharmaceutical Industries. Under a separate deal with Regeneron, Mitsubishi Tanabe Pharma has exclusive development and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.